Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of a Biofeedback Intervention on Microbiome, Metabolome, and Clinical Outcomes in Pediatric IBD

NCT04269720 is registered in ClinicalTrials.gov with Ross Maltz as lead sponsor.

NCT NCT04269720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04269720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of a Biofeedback Intervention on Microbiome, Metabolome, and Clinical Outcomes in Pediatric IBD
Lead sponsor
Ross Maltz
Phase
Not applicable
Overall status
Withdrawn
Start date
September 9, 2022
Completion date
February 1, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ibd